GlassScriptPhysician profile
Lisa Richards
NPI 1669881249
$31,162.60
in general payments reported to CMS, 2019-2025
27 companies · $3,112 in 2025
The $3,112 reported for 2025 was more than what 99% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,157 · 2022: $7,009 · 2023: $11K · 2024: $7,507 · 2025: $3,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,825 · Travel and Lodging: $8,736 · Food and Beverage: $3,436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,825.00 |
| Travel and Lodging | $8,735.50 |
| Food and Beverage | $3,435.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $24,080.68 | 2021-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Pfizer INC. | $2,754.39 | 2021-2025 | |
| Insulet Corporation | $1,806.92 | 2022-2025 | Omnipod, Omnipod |
| Novo Nordisk INC | $477.83 | 2021-2025 | Sogroya, Wegovy, Rybelsus |
| Tandem Diabetes Care, INC. | $390.64 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $346.56 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $246.26 | 2023-2025 | |
| Tolmar, INC. | $194.53 | 2023-2025 | Fensolvi |
| Mannkind Corporation | $109.26 | 2022-2025 | Afrezza |
| Ascendis Pharma Endocrinology INC | $90.79 | 2024-2025 | Skytrofa |
| Neurocrine Biosciences, INC. | $64.05 | 2024-2025 | |
| Sequel Med Tech, LLC | $61.93 | 2025 | Twiist |
| Beta Bionics, INC. | $60.32 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Astrazeneca Pharmaceuticals LP | $58.70 | 2021 | |
| Kyowa Kirin, INC. | $58.52 | 2023-2025 | Crysvita |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $54.81 | 2022-2024 | Freestyle Libre 3 |
| Medtronic, INC. | $46.99 | 2021-2023 | Inpen Smart Insulin Delivery System |
| Eton Pharmaceuticals, INC. | $45.67 | 2025 | Khindivi, Increlex, Alkindi |
| Tolmar Pharmaceuticals, INC. | $32.28 | 2022 | |
| Rhythm Pharmaceuticals, INC. | $32.18 | 2022-2024 | Imcivree |
| Lifescan, INC. | $30.55 | 2022 | |
| Embecta Corp. | $22.98 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Alexion Pharmaceuticals, INC. | $21.82 | 2022 | |
| Zealand Pharma US, INC. | $21.33 | 2022 | |
| Antares Pharma, INC. | $19.64 | 2023 | Nocdurna, Xyosted, Tlando |
| Ipsen Biopharmaceuticals, INC | $17.57 | 2023 | Increlex |
| Amneal Pharmaceuticals LLC | $15.40 | 2025 | Unithroid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.